Pancreatic enzyme supplementation versus placebo for improvement of gastrointestinal symptoms in non-responsive celiac disease: A cross-over randomized controlled trial

BACKGROUND: Pancreatic Exocrine Insufficiency (PEI) is a possible cause of recurrent/persistent symptoms in celiac disease. Although pancreatic enzyme supplementation may be used to treat non-responsive celiac disease (NRCD) in clinical practice, clinical outcomes are variable and there is limited a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoosuf, Shakira, Barrett, Caitlin G., Papamichael, Konstantinos, Madoff, Sarah E., Kurada, Satya, Hansen, Joshua, Silvester, Jocelyn A., Therrien, Amelie, Singh, Prashant, Dennis, Melinda, Leffler, Daniel A., Kelly, Ciaran P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845937/
https://www.ncbi.nlm.nih.gov/pubmed/36687454
http://dx.doi.org/10.3389/fmed.2022.1001879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845937/
https://www.ncbi.nlm.nih.gov/pubmed/36687454
http://dx.doi.org/10.3389/fmed.2022.1001879

Ejemplares similares